Skip to main content

Table 1 Key epidemiological inputs

From: Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19

Epidemiological Parameter

Relative Risk Unvaccinated vs. Fully Vaccinated (Any COVID)

2.4

Relative Risk Unvaccinated vs. Fully Vaccinated (Death)

14

Relative Risk Unvaccinated vs. Fully Vaccinated (Hospitalization)

16

Relative Risk Unvaccinated vs. Fully Vaccinated (ICU)

16

Relative Risk Unvaccinated vs. Fully Vaccinated (MV)

16

Relative Risk Unvaccinated vs. Boosted (Any COVID)

3.2

Relative Risk Unvaccinated vs. Boosted (Death)

41

Relative Risk Unvaccinated vs. Boosted (Hospitalization)

44

Relative Risk Unvaccinated vs. Boosted (ICU)

44

Relative Risk Unvaccinated vs. Boosted (MV)

44